Professor Kim Jeongbeom Recognized for Contributions to National and Social Development

(From left) Professor Kim Jeongbeom, Researcher Lee Hyuna, Researcher Nam Donggyu.

(From left) Professor Kim Jeongbeom, Researcher Lee Hyuna, Researcher Nam Donggyu.

View original image

[Asia Economy Yeongnam Reporting Headquarters Reporter Kim Yong-woo] A startup founded by a UNIST professor to develop a treatment for spinal cord injury received a commendation from the Minister of SMEs and Startups.


UNIST (President Lee Yong-hoon) announced on the 18th that Professor Kim Jung-beom of the Department of Biomedical Engineering received a commendation from the Minister of SMEs and Startups at the 2022 Ulsan Startup Festa (USF) held on the 30th of last month.


Professor Kim was recognized for his contribution to national and social development by founding "Spine Therapeutics," which develops treatments for spinal cord injuries.


At the opening ceremony, the event began with the screening of an opening video titled "Engraving the Heart of Entrepreneurs," followed by an opening performance, awarding of commendations, and a tour of the exhibition hall.


The commendation from the Minister of SMEs and Startups was awarded to CEO Kim Jung-beom of Spine Therapeutics Co., Ltd. and CEO Kim Min-gi of Cheongmyeong Advanced Materials Co., Ltd. for their contributions to entrepreneurship.


The spinal cord injury treatment developed by Spine Therapeutics has shown excellent therapeutic effects not only in small animals but also in medium-sized animals.


GMP production is being promoted for clinical application, and approval procedures are actively underway to obtain authorization from the Ministry of Food and Drug Safety and the U.S. Food and Drug Administration (FDA).



Professor Kim Jung-beom of the Department of Biomedical Engineering said, "I am grateful to UNIST and everyone who supported me from the moment I first started the company until receiving this award," and added, "I will continue to devote myself to research and entrepreneurship to ensure that the research results can be commercialized as treatments applicable to actual patients."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing